| date |
virus |
gene |
work |
doi |
| 2023-02-23 |
SARS-CoV-2 (edit) |
thioredoxin reductase 1 (edit) |
SARS-CoV-2 Main Protease Targets Host Selenoproteins and Glutathione Biosynthesis for Knockdown via Proteolysis, Potentially Disrupting the Thioredoxin and Glutaredoxin Redox Cycles (edit) |
10.3390/ANTIOX12030559 |
| 2022-02-21 |
SARS-CoV-2 (edit) |
HLA-E (edit) |
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells (edit) |
10.1016/J.CELREP.2022.110503 |
| 2021-10-01 |
SARS-CoV-2 (edit) |
Furin, paired basic amino acid cleaving enzyme (edit) |
Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity (edit) |
10.1016/J.VIRUSRES.2021.198522 |
| 2021-07-01 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19 (edit) |
10.1007/S10741-020-10066-6 |
| 2021-06-23 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells (edit) |
10.15252/EMBJ.2021107821 |
| 2021-06-23 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells (edit) |
10.15252/EMBJ.2021107821 |
| 2021-05-27 |
SARS-CoV-2 (edit) |
Transmembrane protein 41B (edit) |
TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1009599 |
| 2021-05-11 |
SARS-CoV-2 (edit) |
TRBV11-2 (edit) |
Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children (edit) |
10.1016/J.IMMUNI.2021.04.003 |
| 2021-04-15 |
SARS-CoV-2 (edit) |
IGHV3-53 (edit) |
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera (edit) |
10.1016/J.CELL.2021.02.033 |
| 2021-03-05 |
SARS-CoV-2 (edit) |
CCHC-type zinc finger nucleic acid binding protein (edit) |
CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands (edit) |
10.3390/IJMS22052614 |
| 2021-02-08 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity (edit) |
10.1038/S41467-021-21118-2 |
| 2021-02-01 |
SARS-CoV-2 (edit) |
BSG (edit) |
Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible? (edit) |
10.1007/S12015-020-10101-X |
| 2021-02-01 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible? (edit) |
10.1007/S12015-020-10101-X |
| 2021-01-01 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective (edit) |
10.1007/S12272-020-01301-7 |
| 2020-11-23 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity (edit) |
10.3389/FMICB.2020.594928 |
| 2020-11-04 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2 (edit) |
10.3390/IJMS21218268 |
| 2020-09-03 |
SARS-CoV-2 (edit) |
heme oxygenase 1 (edit) |
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19) (edit) |
10.3390/IJMS21176412 |
| 2020-08-11 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding (edit) |
10.1016/J.CELL.2020.08.012 |
| 2020-07-29 |
SARS-CoV-2 (edit) |
Translocase of outer mitochondrial membrane 70 (edit) |
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 (edit) |
10.1038/S41423-020-0514-8 |
| 2020-07-22 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner (edit) |
10.1101/2020.07.21.214932 |
| 2020-07-21 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain (edit) |
10.1002/JMV.26319 |
| 2020-07-21 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain (edit) |
10.1002/JMV.26319 |
| 2020-07-21 |
SARS-CoV-2 (edit) |
Furin, paired basic amino acid cleaving enzyme (edit) |
ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain (edit) |
10.1002/JMV.26319 |
| 2020-07-16 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects (edit) |
10.1183/13993003.02378-2020 |
| 2020-07-14 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply (edit) |
10.1007/S11739-020-02436-7 |
| 2020-07-13 |
SARS-CoV-2 (edit) |
FURIN (edit) |
Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva? (edit) |
10.1136/JCLINPATH-2020-206788 |
| 2020-07-10 |
SARS-CoV-2 (edit) |
ACE2 (edit) |
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function (edit) |
10.1101/2020.07.09.196188 |
| 2020-07-01 |
Betacoronavirus (edit) |
C-reactive protein (edit) |
Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review (edit) |
10.1016/J.CLINBIOCHEM.2020.05.012 |
| 2020-06-08 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury (edit) |
10.1002/JCP.29802 |
| 2020-06-01 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection (edit) |
10.1177/0022034520933589 |
| 2020-06-01 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection (edit) |
10.1177/0022034520933589 |
| 2020-05-23 |
SARS-CoV-2 (edit) |
TMPRSS2 (edit) |
Age-related expression of SARS-CoV-2 priming protease TMPRSS2 in the developing lung (edit) |
10.1101/2020.05.22.111187 |
| 2020-05-22 |
SARS-CoV-2 (edit) |
Von Willebrand factor (edit) |
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2 (edit) |
10.1111/IJLH.13244 |
| 2020-05-22 |
SARS-CoV-2 (edit) |
ADAM metallopeptidase with thrombospondin type 1 motif 13 (edit) |
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2 (edit) |
10.1111/IJLH.13244 |
| 2020-05-21 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2 (edit) |
10.1016/J.CELL.2020.05.027 |
| 2020-05-12 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) (edit) |
10.3390/MOLECULES25102271 |
| 2020-05-08 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System (edit) |
10.1161/CIRCRESAHA.120.317015 |
| 2020-05-06 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Cell entry mechanisms of SARS-CoV-2 (edit) |
10.1073/PNAS.2003138117 |
| 2020-05-06 |
SARS-CoV-2 (edit) |
Furin, paired basic amino acid cleaving enzyme (edit) |
Cell entry mechanisms of SARS-CoV-2 (edit) |
10.1073/PNAS.2003138117 |
| 2020-05-06 |
SARS-CoV-2 (edit) |
MX1 (edit) |
Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes (edit) |
10.1101/2020.05.04.075911 |
| 2020-05-06 |
SARS-CoV-2 (edit) |
TMPRSS2 (edit) |
Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes (edit) |
10.1101/2020.05.04.075911 |
| 2020-05-01 |
SARS-CoV-2 (edit) |
transmembrane serine protease 4 (edit) |
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes (edit) |
10.1126/SCIIMMUNOL.ABC3582 |
| 2020-05-01 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes (edit) |
10.1126/SCIIMMUNOL.ABC3582 |
| 2020-04-27 |
SARS-CoV-2 (edit) |
ACE2 (edit) |
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues (edit) |
10.1016/J.CELL.2020.04.035 |
| 2020-04-22 |
SARS-CoV-2 (edit) |
PIKFYVE (edit) |
Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2 (edit) |
10.1101/2020.04.21.053058 |
| 2020-04-20 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Broad and differential animal ACE2 receptor usage by SARS-CoV-2 (edit) |
10.1101/2020.04.19.048710 |
| 2020-04-01 |
Betacoronavirus (edit) |
angiotensin I converting enzyme 2 (edit) |
The proximal origin of SARS-CoV-2 (edit) |
10.1038/S41591-020-0820-9 |
| 2020-04-01 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
The proximal origin of SARS-CoV-2 (edit) |
10.1038/S41591-020-0820-9 |
| 2020-03-27 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19 (edit) |
10.1101/2020.03.21.20040261 |
| 2020-03-20 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells (edit) |
10.26434/CHEMRXIV.12009582 |
| 2020-03-05 |
SARS-CoV-2 (edit) |
IL6 (edit) |
Effective Treatment of Severe COVID-19 Patients with Tocilizumab (edit) |
|
| 2020-03-04 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics (edit) |
10.1002/DDR.21656 |
| 2020-03-04 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (edit) |
10.1016/J.CELL.2020.02.052 |
| 2020-03-04 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (edit) |
10.1016/J.CELL.2020.02.052 |
| 2020-03-04 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2 (edit) |
10.1126/SCIENCE.ABB2762 |
| 2020-03-03 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target (edit) |
10.1007/S00134-020-05985-9 |
| 2020-02-24 |
Betacoronavirus (edit) |
angiotensin I converting enzyme 2 (edit) |
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses (edit) |
10.1038/S41564-020-0688-Y |
| 2020-02-24 |
SARS-CoV-2 (edit) |
angiotensin I converting enzyme 2 (edit) |
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses (edit) |
10.1038/S41564-020-0688-Y |
| 2020-02-01 |
SARS-CoV-2 (edit) |
Transmembrane serine protease 2 (edit) |
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells (edit) |
10.1101/2020.01.31.929042 |
| 2020-01-21 |
Middle East respiratory syndrome coronavirus (edit) |
Dipeptidyl peptidase 4 (edit) |
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus (edit) |
10.1080/22221751.2020.1713705 |
| 2019-03-05 |
Middle East respiratory syndrome coronavirus (edit) |
Transmembrane serine protease 2 (edit) |
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection (edit) |
10.1128/JVI.01815-18 |
| 2019-03-05 |
SARS-CoV-1 (edit) |
Transmembrane serine protease 2 (edit) |
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection (edit) |
10.1128/JVI.01815-18 |
| 2017-02-01 |
Middle East respiratory syndrome coronavirus (edit) |
Dipeptidyl peptidase 4 (edit) |
Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. (edit) |
10.18632/ONCOTARGET.14754 |
| 2016-06-30 |
Human coronavirus 229E (edit) |
TMPRSS2 (edit) |
HeLa-ACE2-TMPRSS2 Cells Are Useful for the Isolation of Human Coronavirus 229E. (edit) |
10.7883/YOKEN.JJID.2016.106 |
| 2016-06-30 |
Human coronavirus 229E (edit) |
angiotensin I converting enzyme 2 (edit) |
HeLa-ACE2-TMPRSS2 Cells Are Useful for the Isolation of Human Coronavirus 229E. (edit) |
10.7883/YOKEN.JJID.2016.106 |
| 2015-10-01 |
Human coronavirus 229E (edit) |
peptidylprolyl isomerase A (edit) |
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication (edit) |
10.1016/J.COVIRO.2015.08.004 |
| 2014-01-01 |
SARS-CoV-1 (edit) |
Hepsin (edit) |
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein (edit) |
10.1128/JVI.02202-13 |
| 2014-01-01 |
SARS-CoV-1 (edit) |
Transmembrane serine protease 11D (edit) |
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein (edit) |
10.1128/JVI.02202-13 |
| 2014-01-01 |
SARS-CoV-1 (edit) |
Transmembrane serine protease 2 (edit) |
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein (edit) |
10.1128/JVI.02202-13 |
| 2014-01-01 |
SARS-CoV-1 (edit) |
angiotensin I converting enzyme 2 (edit) |
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein (edit) |
10.1128/JVI.02202-13 |
| 2014-01-01 |
SARS-CoV-1 (edit) |
ADAM metallopeptidase domain 17 (edit) |
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein (edit) |
10.1128/JVI.02202-13 |
| 2013-10-30 |
SARSr-CoV (edit) |
angiotensin I converting enzyme 2 (edit) |
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (edit) |
10.1038/NATURE12711 |
| 2013-10-30 |
SARS-CoV-1 (edit) |
angiotensin I converting enzyme 2 (edit) |
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (edit) |
10.1038/NATURE12711 |
| 2013-03-27 |
Human coronavirus 229E (edit) |
Transmembrane serine protease 2 (edit) |
TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium (edit) |
10.1128/JVI.03372-12 |
| 2011-02-16 |
SARS-CoV-1 (edit) |
Transmembrane serine protease 2 (edit) |
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response (edit) |
10.1128/JVI.02232-10 |
| 2011-01-01 |
SARSr-CoV (edit) |
Interferon induced transmembrane protein 3 (edit) |
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit) |
10.1371/JOURNAL.PPAT.1001258 |
| 2011-01-01 |
SARSr-CoV (edit) |
Interferon induced transmembrane protein 2 (edit) |
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit) |
10.1371/JOURNAL.PPAT.1001258 |
| 2011-01-01 |
SARSr-CoV (edit) |
Interferon induced transmembrane protein 1 (edit) |
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit) |
10.1371/JOURNAL.PPAT.1001258 |
| 2011-01-01 |
SARS-CoV-1 (edit) |
Interferon induced transmembrane protein 3 (edit) |
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit) |
10.1371/JOURNAL.PPAT.1001258 |
| 2011-01-01 |
SARS-CoV-1 (edit) |
Interferon induced transmembrane protein 2 (edit) |
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit) |
10.1371/JOURNAL.PPAT.1001258 |
| 2011-01-01 |
SARS-CoV-1 (edit) |
Interferon induced transmembrane protein 1 (edit) |
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit) |
10.1371/JOURNAL.PPAT.1001258 |
| 2010-11-10 |
SARS-CoV-1 (edit) |
Transmembrane serine protease 2 (edit) |
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry (edit) |
10.1128/JVI.02062-10 |
| 2010-11-10 |
SARS-CoV-1 (edit) |
angiotensin I converting enzyme 2 (edit) |
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry (edit) |
10.1128/JVI.02062-10 |
| 2009-01-01 |
SARSr-CoV (edit) |
MASP2 (edit) |
Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection (edit) |
10.1186/1471-2334-9-51 |
| 2009-01-01 |
SARS-CoV-1 (edit) |
MASP2 (edit) |
Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection (edit) |
10.1186/1471-2334-9-51 |
| 2008-05-19 |
SARS-CoV-1 (edit) |
TNF (edit) |
Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry (edit) |
10.1073/PNAS.0711241105 |
| 2008-05-19 |
SARS-CoV-1 (edit) |
angiotensin I converting enzyme 2 (edit) |
Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry (edit) |
10.1073/PNAS.0711241105 |
| 2008-05-02 |
SARSr-CoV (edit) |
angiotensin I converting enzyme 2 (edit) |
Lipid rafts are involved in SARS-CoV entry into Vero E6 cells (edit) |
10.1016/J.BBRC.2008.02.023 |
| 2008-05-02 |
SARS-CoV-1 (edit) |
angiotensin I converting enzyme 2 (edit) |
Lipid rafts are involved in SARS-CoV entry into Vero E6 cells (edit) |
10.1016/J.BBRC.2008.02.023 |
| 2008-04-01 |
human Coronavirus NL63 (edit) |
angiotensin I converting enzyme 2 (edit) |
Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction (edit) |
10.1099/VIR.0.83331-0 |
| 2008-02-29 |
SARSr-CoV (edit) |
TNF (edit) |
Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study (edit) |
10.1186/1471-2334-8-27 |
| 2007-04-11 |
SARS-CoV-1 (edit) |
BCL2 like 1 (edit) |
Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein (edit) |
10.1128/JVI.00090-07 |
| 2007-04-11 |
SARS-CoV-1 (edit) |
BCL2 associated X, apoptosis regulator (edit) |
Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein (edit) |
10.1128/JVI.00090-07 |
| 2005-09-01 |
SARS-CoV-1 (edit) |
C-type lectin domain family 4 member G (edit) |
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus (edit) |
10.1016/J.VIROL.2005.06.026 |
| 2004-11-02 |
SARS-CoV-1 (edit) |
C-type lectin domain family 4 member M (edit) |
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus (edit) |
10.1073/PNAS.0403812101 |
| 2004-06-01 |
SARS-CoV-1 (edit) |
angiotensin I converting enzyme 2 (edit) |
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. (edit) |
10.1002/PATH.1570 |
| 2004-06-01 |
SARSr-CoV (edit) |
angiotensin I converting enzyme 2 (edit) |
ACE2: from vasopeptidase to SARS virus receptor (edit) |
10.1016/J.TIPS.2004.04.001 |
| 2004-06-01 |
SARS-CoV-1 (edit) |
angiotensin I converting enzyme 2 (edit) |
ACE2: from vasopeptidase to SARS virus receptor (edit) |
10.1016/J.TIPS.2004.04.001 |
| 1992-06-04 |
Human coronavirus 229E (edit) |
Alanyl aminopeptidase, membrane (edit) |
Human aminopeptidase N is a receptor for human coronavirus 229E (edit) |
10.1038/357420A0 |
This SPARQL query is available under CCZero.